Alternation of epirubicin and mitoxantrone in CHOP-like regimens retains efficacy and reduces overall toxicity in elderly patients with high and intermediate grade non-Hodgkin lymphomas.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples